全球数位化糖尿病管理市场规模、份额、趋势和成长分析报告（2026-2034年）

数位糖尿病管理市场预计将从 2025 年的 311.8 亿美元成长到 2034 年的 1,016.2 亿美元，2026 年至 2034 年的复合年增长率为 14.03%。

随着数位医疗技术的蓬勃发展，全球数位糖尿病管理市场正迅速扩张。全球糖尿病患者数量的不断增长，推动了对持续监测和管理工具的需求。行动应用程式、穿戴式装置和连网血糖监测仪等工具，有助于提高患者参与治疗的积极性，并改善治疗效果。

智慧型手机和穿戴式健康设备的普及是主要驱动因素。自疫情爆发以来，远端医疗服务和远端患者监护系统得到了广泛应用。人们对自我护理和预防医学的认识不断提高，也促进了市场成长。此外，医疗服务提供者也正在采用数位化平台，以便更有效地追踪病患资料。

展望未来，人工智慧 (AI) 和数据分析技术的进步预计将推动市场强劲成长。数位工具与医疗保健系统的整合有望改善个人化治疗方案的发展。然而，对资料隐私的担忧以及设备高成本可能会限制某些地区的普及应用。总体而言，医疗保健产业的数位转型将支持其长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球数位化糖尿病管理市场：依产品与服务划分

• 市场分析、洞察与预测
• 设备（智慧血糖仪、持续血糖监测（CGM）系统、智慧胰岛素笔、智慧胰岛素帮浦/闭合迴路帮浦、智慧胰岛素贴片）
• 应用程式（糖尿病/血糖值管理应用程式、肥胖/饮食管理应用程式）
• 资料管理软体和平台
• 服务

第五章 全球数位糖尿病管理市场：依设备类型划分

• 市场分析、洞察与预测
• 手持装置
• 穿戴式装置

第六章 全球数位糖尿病管理市场：依最终用户划分

• 市场分析、洞察与预测
• 自我/居家医疗保健
• 医院及糖尿病专科诊所
• 学术研究机构

第七章 全球数位糖尿病管理市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Medtronic
  • B. Braun Melsungen AG
  • Dexcom Inc
  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Insulet Corporation
  • Tandem Diabetes Care
  • Ascensia Diabetes Care Holdings AG
  • LifeScan Inc
  • Tidepool
  • AgaMatrix
  • Glooko Inc

The Digital Diabetes Management Market size is expected to reach USD 101.62 Billion in 2034 from USD 31.18 Billion (2025) growing at a CAGR of 14.03% during 2026-2034.

The global digital diabetes management market has expanded rapidly with the growth of digital health technologies. Rising diabetes cases worldwide have increased the need for continuous monitoring and management tools. Mobile apps, wearable devices, and connected glucose monitors have improved patient engagement and treatment outcomes.

Major drivers include the increasing use of smartphones and wearable health devices. Telemedicine services and remote patient monitoring systems have gained popularity, especially after the pandemic. Growing awareness about self-care and preventive healthcare supports market growth. Healthcare providers are also adopting digital platforms to track patient data more effectively.

Looking ahead, the market is expected to grow strongly with advancements in artificial intelligence and data analytics. Integration of digital tools with healthcare systems will improve personalized treatment plans. However, data privacy concerns and high device costs may limit adoption in some regions. Overall, digital transformation in healthcare will support long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Devices (Smart Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-Loop Pumps & Smart Insulin Patches)
• Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps)
• Data Management Software & Platforms
• Services

By Device Type

• Handheld Devices
• Wearable Devices

By End User

• Self/Home Healthcare
• Hospitals & Specialty Diabetes Clinics
• Academic & Research Institutes

COMPANIES PROFILED

• Medtronic, B Braun Melsungen AG, Dexcom Inc, Abbott Laboratories, F HoffmannLa Roche, Insulet Corporation, Tandem Diabetes Care, Ascensia Diabetes Care Holdings AG, LifeScan Inc, Tidepool, AgaMatrix, Glooko Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Devices (Smart Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-Loop Pumps & Smart Insulin Patches) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Data Management Software & Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Device Type
• 5.2. Handheld Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Wearable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Self/Home Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals & Specialty Diabetes Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product & Service
  • 7.2.2 By Device Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product & Service
  • 7.3.2 By Device Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product & Service
  • 7.4.2 By Device Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product & Service
  • 7.5.2 By Device Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product & Service
  • 7.6.2 By Device Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DIGITAL DIABETES MANAGEMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 B. Braun Melsungen AG
  • 9.2.3 Dexcom Inc
  • 9.2.4 Abbott Laboratories
  • 9.2.5 F. Hoffmann-La Roche
  • 9.2.6 Insulet Corporation
  • 9.2.7 Tandem Diabetes Care
  • 9.2.8 Ascensia Diabetes Care Holdings AG
  • 9.2.9 LifeScan Inc
  • 9.2.10 Tidepool
  • 9.2.11 AgaMatrix
  • 9.2.12 Glooko Inc